Blackstone Inc’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
QF
FCM
Blackstone Inc's ROIV Position: Q2 2026 in Review
Blackstone Inc reduced its Roivant Sciences (ROIV) stake by 87% in Q2 2026, selling an estimated $2.36M and leaving 12,447 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #374.
Blackstone Inc first reported a position in ROIV in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.84M in Q4 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.
- Blackstone Inc held 12,447 shares of Roivant Sciences worth $440K as of Q2 2026.
- Blackstone Inc sold 79,925 Roivant Sciences shares in Q2 2026, an estimated $2.36M.
- Roivant Sciences made up ﹤0.01% of Blackstone Inc's portfolio in Q2 2026, its #374 holding.
- Blackstone Inc first reported a position in Roivant Sciences in Q3 2025 and has held it in 4 quarters since.
- Blackstone Inc's Roivant Sciences position peaked at $4.84M in Q4 2025.
- 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.
Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.